CoChat
Sign Up
Cited by 121Bariatric Surgery and OutcomesBone health and osteoporosis researchParathyroid Disorders and Treatments

The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.

Bone metabolism and risk of secondary hyperparathyroidism 12 months after gastric banding in obese pre-menopausal women

Pugnale, N, Giusti, V, Suter, M, Zysset, E, Héraïef, E, Gaillard, R C, Burckhardt, P·2003·International Journal of Obesity
DOI 10.1038/sj.ijo.0802177
Open this paper in CoChat — free account

Abstract

Objective To evaluate, during the first postoperative year in obese pre-menopausal women, the effects of laparoscopic gastric banding on calcium and vitamin D metabolism, the potential modifications of bone mineral content and bone mineral density, and the risk of development of secondary hyperparathyroidism.Subjects Thirty-one obese pre-menopausal women aged between 25 and 52 y with a mean body mass index (BMI) of 43.6 kg/m(2), scheduled for gastric banding were included. Patients with renal, hepatic, metabolic and bone disease were excluded.Methods Body composition and bone mineral density (BMD) were measured at baseline, 6 and 12 months after gastric banding using dual-energy X-ray absorptiometry. Serum calcium, phosphate, alkaline phosphatase, aspartate aminotransferase, alanine aminotransferase, gamma-glutamyltransferase, bilirubin, urea, creatinine, uric acid, proteins, parathormone, vitamin D(3), IGF-1, IGF-BP3 and telopeptide, as well as urinary telopeptide, were measured at baseline and 1, 3, 6, 9 and 12 months after surgery.Results After 1 y vitamin D3 remained stable and PTH decreased by 12%, but the difference was not significant. Serum telopeptide C increased significantly by 100% (P<0.001). There was an initial drop of the IGF-BP3 during the first 6 months (P<0.05), but the reduction was no longer significant after 1 y. The BMD of cortical bone (femoral neck) decreased significantly and showed a trend of a positive correlation with the increase of telopeptides (P<0.06). The BMD of trabecular bone, at the lumbar spine, increased proportionally to the reduction of hip circumference and of body fat.Conclusion There is no evidence of secondary hyperparathyroidism 1 y after gastric banding. Nevertheless biochemical bone markers show a negative remodelling balance, characterized by an increase of bone resorption. The serum telopeptide seems to be a reliable parameter, not affected by weight loss, to follow up bone turnover after gastroplasty.

Overview

Integrity signals

Registry

Crossref · 10.1038/sj.ijo.0802177

Cites

54 of 54 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 54 references

Research works printed but not linked: 2

  1. Compston JE, Horton LWL & Laker MF et al . Bone disease after jejunoileal bypass for obesity. Lancet 1974; ii: 1–4.
  2. Statistical Bulletin Metrop. Life Insurance Co. no. 40. November–December 1959.

Cited by

Sorted by citations

Items 101–121 of 121

Related

See all

Metadata

Authors
Pugnale, N., Giusti, V, Suter, M., Zysset, E., Héraïef, E., Gaillard, R. C., & Burckhardt, P.
Affiliations
Centre Hospitalier Universitaire Vaudois (CH)
Corresponding author
Giusti, V
ORCID
Venue
International Journal of Obesity
Publisher
Springer Science and Business Media LLC
Published
2003-01
Volume
27
Issue
1
Pages
110-116
ISSN
  • 0307-0565 (ISSN-L)
  • 1476-5497
DOI
10.1038/sj.ijo.0802177
OpenAlex
W2070301360
Cited by
121
References
54
Citations by year
2024: 2 · 2022: 2 · 2021: 2 · 2020: 3 · 2019: 3 · 2018: 4 · 2017: 4 · 2016: 6 · 2015: 10 · 2014: 11 · 2013: 4 · 2012: 9
FWCI
3.52
Type
journal article
Language
en
Open access
closed
Licence
www.springer.com/tdm (tdm)
Locations
  • International Journal of Obesity (publishedVersion)
  • PubMed (publishedVersion)
  • IRIS (submittedVersion)
  • SERVAL (Université de Lausanne) (submittedVersion)
Topics
  • Health Sciences › Medicine › Surgery › Bariatric Surgery and Outcomes
  • Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
  • Health Sciences › Medicine › Nephrology › Parathyroid Disorders and Treatments
Keywords
gastric banding, bariatric surgery, secondary hyperparathyroidism, bone metabolism, bone mineral density, bone turnover markers, telopeptides, vitamin D, parathyroid hormone, IGFBP-3, obesity, premenopausal women, bone resorption, weight loss
MeSH terms
Adult, Calcium, Female, Follow-Up Studies, Gastroscopy, Humans, Hyperparathyroidism, Secondary, Middle Aged, Obesity, Morbid, Risk Factors, Vitamin D, Gastric Bypass, Bone Density, Body Mass Index, Bone Remodeling, Premenopause

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review